HC106

· Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HC106, covering 2025-05-01 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old [Phase 1]

See pricing